Traditional Chinese medicine composition used for treating aplastic anemia

Abstract

The invention discloses a traditional Chinese medicine composition used for treating aplastic anemia. The composition is composed of the raw materials of, by weight: 10-12 parts of pilose asiabell root, 4-6 parts of common jujube, 2-4 parts of Mongolian milkvetch root, 5-7 parts of ligusticum, 2-4 parts of prepared rehmannia root, 7-9 parts of Szechwan lovage rhizome, 10-12 parts of medlar, 3-5 parts of largehead atractylodes rhizome, 2-4 parts of tuber fleeceflower root, 5-7 parts of turtle shell, 3-5 parts of epimedium, 2-4 parts of ass-hide gelatin, 5-7 parts of dried human placenta, 1-3 parts of suberect spatholobus stem, 3-5 parts of kadsura root-bark, 5-7 parts of snakegourd root, 2-4 parts of cuttlebone, 6-8 parts of kalimeris indica, 3-5 parts of fragrant plantain lily, 1-3 parts of Japanese raspberry root, 1-3 parts of jatamana valeriana rhizome, and 8-10 parts of lotus seedpod. The traditional Chinese medicine composition is provided with a traditional Chinese medical science theory. The medicine materials are formulated such that qi-benefiting, yin-nourishing, heat-clearing, blood-cooling, stasis-removing, bleeding-stopping, spleen-invigorating, and stomach-nourishing functions are provided. With the medicine composition, bone marrow hematopoietic function can be effectively stimulated, and immunity can be regulated. The medicine composition has good clinical treatment effect in treating aplastic anemia, and has the advantages of low cost, good treatment effect, and reoccurrence prevention.

Description

technical field [0001] The invention relates to a traditional Chinese medicine composition for treating aplastic anemia, belonging to the field of traditional Chinese medicines. Background technique [0002] Aplastic anemia belongs to the category of consumptive symptoms and blood syndrome in traditional Chinese medicine. Traditional Chinese medicine believes that the occurrence of this disease is related to the heart, liver, spleen, and kidney organs. Asthenic fire is endogenous; current western medicine treatment is mainly symptomatic treatment and immunosuppressive treatment, there are many adverse reactions, immunosuppressive treatment will cause the patient's resistance to decline, and it is easy to cause some complications; the cure rate of western medicine treatment is relatively low, and after curing Easy to relapse, adopt Western medicine treatment to the injury of human body bigger, and the course for the treatment of is longer. Contents of the invention [0003...

AI Technical Summary

Problems solved by technology

[0002] Aplastic anemia belongs to the category of consumptive symptoms and blood syndrome in traditional Chinese medicine. Traditional Chinese medicine believes that the occurrence of this disease is related to the heart, liver, spleen, and kidney organs. Asthenic fire is endogenous; current western medicine treatment is mainly symptomatic treatment and immunosuppressive treatment, there are many adverse reactions, immunosuppressive treatment will cause the patient's resistance to decline, and it is easy to cause some complications; the cure rate of western medicine treatment is relatively low, and after curing Easy to relapse, the use of western medicine will cause greater damage to the human body, and the course of treatment is longer